How to Use a Retatrutide Pen
This guide walks through how to use the 30mg retatrutide pen — its specs (300 clicks, 0.1mg per click, 60-click max dial), priming, the six-step injection sequence, refrigerated 2–8°C storage, and needle fit. For exact mg-to-click lookup use the pen clicks guide; for pen-count and duration math use the retatrutide pen how many clicks calculator; for the TRIUMPH titration schedule see the dosage guide.
Update History ▾
June 6, 2026: Retitled for research-handling intent, tightened RUO snippet language, and replaced instruction-style FAQ wording with device documentation context.
June 1, 2026: Shortened SERP title, softened handling language, and aligned supporting feed and LLM summaries after Surfer review.
May 25, 2026: Aligned dateModified and routed device-specific readers to the retatrutide research hub for trials, approval status, dosing, and Dubai context.
May 24, 2026: Removed 28-day in-use window references across subtitle, key specs, storage table, body, FAQ, and JSON-LD
May 24, 2026: Retitled for "how to use retatrutide pen" keyword; tightened Step 5 with receptor mechanism, added once-weekly research-protocol framing, refreshed pen-vs-vial comparison
April 26, 2026: Refreshed structure with administration steps, pen-vs-vial comparison, and storage clarifications
April 14, 2026: Removed click-table overlap, stripped commercial routing, and tightened the page around hardware, storage, priming, and needle fit
April 13, 2026: Tightened device-first positioning, clarified calculator versus clicks-chart routing, and refreshed the storage/priming promise
April 8, 2026: Repositioned the page around pen mechanics, storage, and handling rather than general dose-planning
March 14, 2026: Initial publication
The 30mg retatrutide pen is a prefilled, multi-dose device: 30mg total, 300 clicks, 0.1mg per click, and a 60-click / 6mg maximum dial per injection. Use runs in six steps — room-temperature equilibration, a fresh needle, a 2-click prime, dialling the required clicks, subcutaneous delivery with a ~10-second hold, then needle removal and refrigerated storage — each walked through below, alongside specs, storage, and needle fit. For exact dose conversions, use the pen clicks chart. For pen-duration and pen-count math, use the retatrutide pen how many clicks calculator. For the TRIUMPH titration schedule, use the dosage guide. For the full molecule route through trials, approval status, dosing, and Dubai availability, use the retatrutide research hub. For research-use availability, batch proof, and formats in the UAE, see Retatrutide UAE formats.
- 30mg total retatrutide per pen
- 300 clicks per pen
- 0.1mg per click
- 60-click / 6mg max single dial
- 30G or 31G needle, 4–8mm
How the Retatrutide Pen Works
A retatrutide pen is a prefilled, multi-dose subcutaneous delivery device holding retatrutide in a ready-to-use liquid formulation.[6] Unlike a lyophilised vial that must be reconstituted with bacteriostatic water before each use, the pen ships pre-loaded and uses a click-based dial mechanism for precise dose selection. Each click of the dial dispenses exactly 0.1mg of retatrutide — mechanical, repeatable, and independent of syringe markings.
This guide covers how to use the pen end to end: the hardware (30mg total, 300 clicks, 0.1mg per click), priming, the injection sequence, storage, and which needles fit. For the regulatory picture see the approval page; for the week-by-week TRIUMPH titration schedule see the dosage guide; and for the exact mg-to-click lookup table see the clicks guide.
The pen format suits research protocols that demand repeated, precisely metered doses across multi-week titration schedules. The dial supports stepwise escalation and protocol-defined adjustments mirroring the dose arms used across published Phase 2 and Phase 3 retatrutide trials.[1][3] If you need the weekly titration schedule, use the dosage guide. For direct mg-to-click conversion, use the clicks chart. For pen-count and protocol-length planning, use the calculator.
What Are the Pen Specifications?
The retatrutide 30mg pen is a prefilled multi-dose device, with retatrutide solution delivered through the pen format. The nine spec rows below cover everything you need before reaching for the pen clicks guide or calculator.
| Specification | Detail |
|---|---|
| Format | Prefilled Pen |
| Total Content | 30mg retatrutide |
| Total Clicks | 300 clicks |
| Dose per Click | 0.1mg |
| Maximum Single Dose | 60 clicks (6mg) |
| Administration | Subcutaneous injection |
| Needle Compatibility | Standard pen dispensing needles (30G/31G, 4–8mm) |
| Storage (unopened) | 2–8°C (refrigerated) |
| Storage (in use) | Refrigerated (2–8°C) — return after each use |
The 60-click cap per injection is a mechanical limit of the dial — it physically stops at 60. Targets above 6mg are split across separate injections; for the exact split-dose lookup table, use the retatrutide pen clicks guide. The TRIUMPH Phase 3 program titrates retatrutide stepwise up to a 12mg weekly target dose, and the full escalation schedule lives in the dosage guide.[3]
How Do You Use a Retatrutide Pen?
Six steps cover the full cycle, from taking the pen out of the fridge to storing it again. Once the pen has reached room temperature the whole sequence takes about five minutes. The steps below describe how the device operates, for research handling and documentation — Remy Peptides products are supplied for in-vitro laboratory research only, not human or veterinary use.
Step 1 — Prepare
Take the pen out of the refrigerator 15–30 minutes before use so it reaches room temperature — equilibration does not change the formulation. Inspect the cartridge through the viewing window — the solution should be clear and colourless, with no particles or cloudiness. Set the pen aside if the contents are discoloured, particulate, or have been frozen.
Step 2 — Attach the Needle
Peel the paper seal from a fresh single-use pen needle, then screw or push it straight onto the pen tip until it is secure. Remove the outer cap (keep it for disposal) and the inner cap. Use a new needle for every injection — reused needles dull, can contaminate the solution, and risk leakage. The pen takes standard 30G/31G pen needles; the full needle-compatibility table is further down.
Step 3 — Prime
Priming a reta pen clears air from the cartridge and confirms the dial-to-needle path is open. Dial 2 clicks (0.2mg), hold the pen with the needle pointing up, tap the cartridge to move any air bubbles to the top, then press the plunger until a drop appears at the needle tip. If no drop appears, repeat. Prime every time you fit a new needle.
Step 4 — Dial the Dose
Turn the dial to the required number of clicks — each click is 0.1mg. The dial moves both ways, so an over-dial corrects back without wasting solution, and the mechanical cap is 60 clicks (6mg) per injection. The TRIUMPH Phase 3 program titrates retatrutide stepwise up to a 12mg weekly target.[3] For the week-by-week schedule use the dosage guide, for mg-to-click lookup use the pen clicks guide, and for pen-count math use the calculator.
Step 5 — Subcutaneous Injection
In the published trial programs, retatrutide was administered as a once-weekly subcutaneous injection.[1] On the pen, delivery is perpendicular (90°): the plunger is pressed fully until the pen clicks to confirm the dose is complete, then held in place for about 10 seconds before withdrawal so the full dose clears the cartridge.[6] The 10-second hold is what prevents leakage at the needle tip. Across the published Phase 2 and Phase 3 retatrutide trials, the most frequently reported adverse events were gastrointestinal — nausea, vomiting, diarrhoea, and constipation — and tended to be dose-dependent;[1] the tolerability data is summarised in the retatrutide profile.
Step 6 — Remove the Needle & Store
Twist or pull the used needle off the pen and drop it straight into a sharps container. Replace the cap and return the pen straight to refrigerated storage at 2–8°C — do not leave it at room temperature.
When Should You Use the Clicks Guide or Calculator?
This page is the device reference for pen format, storage, compatibility, and click-limit context, while the linked resources handle dose math and schedule planning. Three sibling pages handle the rest:
- Mg-to-click lookup: use the retatrutide pen clicks guide for the exact conversion table, including split-dose entries above the 60-click dial cap.
- Pen-count and protocol-length math: use the retatrutide pen how many clicks calculator to model how many pens a multi-week titration burns through.
- Weekly titration schedule: use the dosage guide for the stepwise TRIUMPH escalation pattern.[3]
Pen vs Lyophilised Vial — Which Format?
Retatrutide is available in two delivery formats: prefilled pens (10mg entry pen, 20mg pen, 30mg flagship pen, 40mg high-load pen) and lyophilised powder vials (10mg vial, 40mg vial). The trade-offs in the retatrutide pen vs vial choice cluster around accuracy, convenience, contamination risk, and cost per milligram — the same format comparison researchers run across GLP-1 and multi-agonist research compounds.
| Factor | Prefilled Pen | Lyophilised Vial |
|---|---|---|
| Preparation | Ready to use — no mixing | Requires reconstitution with bacteriostatic water |
| Dosing Accuracy | 0.1mg per click — mechanical precision | Depends on syringe volume markings |
| Contamination Risk | Low — sealed cartridge, no open transfer | Higher — multi-step reconstitution introduces contamination vectors |
| Convenience | High — dial, dispense, store | Low — requires vials, syringes, BAC water, mixing |
| Portability | Compact, self-contained | Requires carrying separate supplies |
| Cost per mg | Higher upfront cost | Typically lower per mg |
| Shelf Life (unopened) | Refrigerated, manufacturer specified | Longer — lyophilised powder is more stable |
| Skill Required | Minimal — no reconstitution knowledge needed | Moderate — must understand reconstitution ratios |
For most research protocols, the pen format offers the best balance of accuracy, convenience, and contamination control. The vial format may be preferred when cost per milligram is the primary consideration or when researchers need to prepare custom concentrations, including cases where the protocol calls for mixing with a sterile diluent before dispensing. For a broader comparison of retatrutide against other compounds, see our retatrutide vs tirzepatide comparison.
How Should a Retatrutide Pen Be Stored?
Knowing how to store a retatrutide pen protects peptide integrity and keeps research results consistent. Retatrutide degrades when exposed to heat, light, or repeated freeze-thaw cycles, so the cold chain matters from delivery onward.
Before First Use
- Store at 2–8°C (standard refrigerator temperature)
- Do not freeze — freezing can damage the peptide structure and the pen mechanism
- Keep in original packaging to protect from light
- Store upright if possible
After First Use
- Always return to refrigerated storage (2–8°C) after each use — do not store at room temperature
- Do not expose to temperatures above 30°C
- Avoid direct sunlight or prolonged UV exposure
- Always remove the needle after each use to prevent contamination and leakage
So what happens if a retatrutide pen gets warm? Brief room-temperature exposure during use is expected, but sustained heat above 30°C or direct sun accelerates degradation — a pen left in a hot car or shipped without a cold chain should be treated as compromised. For underlying peptide degradation kinetics, see the peptide stability and storage guide. In hot climates such as the UAE — where ambient temperatures regularly exceed 45°C — temperature-controlled transport and refrigerated storage are non-negotiable. The Retatrutide UAE supply page covers the cold-chain logistics we use for Dubai-based research orders, and the broader UAE peptide catalog lists every research compound currently in stock.
What Needles Are Compatible?
Needles for the retatrutide pen are standard screw-on pen needles — the same universal fitting used by most prefilled pen injectors. Pen needles are sold separately and should be single-use only.
| Needle Spec | Recommended | Notes |
|---|---|---|
| Gauge | 30G or 31G | Smaller outer diameter |
| Length | 4mm or 5mm | Common length for subcutaneous delivery devices |
| Alternative Length | 6mm or 8mm | Protocol-dependent alternative |
| Brands | BD Micro-Fine, NovoFine, Owen Mumford | Any standard pen needle with universal screw-on fitting |
Key needle rules: Always use a new needle for each injection. Never leave a needle attached to the pen between uses — this can cause air entry, contamination, and solution leakage. Dispose of used needles in a proper sharps container immediately after use.
Our Research Standards
This article cites peer-reviewed studies, FDA filings, and ClinicalTrials.gov data. All claims are cross-referenced against primary sources. We update articles when new trial data or regulatory decisions are published. Read our editorial policy →
Sources
- Jastreboff AM, et al. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. N Engl J Med. 2023;389(6):514–526. nejm.org
- Janoshik Analytical — Certificate of Analysis, Batch RETP002. HPLC purity: 99.262%. remypeptides.com/coa
- Eli Lilly. TRIUMPH Clinical Trial Program for Retatrutide. clinicaltrials.gov ↩
- Rosenstock J, et al. Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-comparator-controlled, parallel-group, phase 2 trial. Lancet. 2023;402(10401):529–544.
- Frias JP, et al. Efficacy and safety of LY-3437943, a novel triple GIP/GLP-1/glucagon receptor agonist in patients with type 2 diabetes. Lancet. 2022;400(10366):1869–1881.
- USP General Chapter <1>. Injections and Implanted Drug Products. United States Pharmacopeia. ↩